-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
CNS Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2018 to Q3 2024.
- CNS Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 696 %.
- CNS Pharmaceuticals, Inc. annual Return On Equity for 2023 was 33.3K %.
- CNS Pharmaceuticals, Inc. annual Return On Equity for 2022 was -151 %, a 1.56% decline from 2021.
- CNS Pharmaceuticals, Inc. annual Return On Equity for 2021 was -149 %, a 2.49% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)